The YouTuber advises caution with Revolution Medicines, a clinical-stage oncology biotech, despite Google's investment. He notes its very early-stage pipeline and the significant expertise required to evaluate biotech investments, warning of high risk for general investors due to potential clinical trial failures.
“to be successful investing in biotechnology you really need to understand not just the research but also the clinical trial schedule and the FDA approval process”